A CLINICAL TRIAL TO STUDY THE EFFECTS OF KATI BASTI(RETAINING OIL IN LOWER BACK) WITH MOORCHITA TAILA(MEDICATED OIL) AND ERANDAKARKATI TAILA( UNRIPE PAPAYA OIL) IN SCIATICA

AN OPEN LABEL DOUBLE ARM RANDOMISED STUDY TO COMPARE THE EFFECT OF KATIBASTI WITH MOORCHITA TAILA AND KATI BASTI WITH ERANDAKARKATI TAILA IN GRIDHRASI VIS-Ã?-VIS SCIATICA - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031055

Enrollment

Registered

2021-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G541- Lumbosacral plexus disorders

Interventions

Intervention1: Kati basti with Erandakarkati taila: KATI BASTI WITH ERANDAKARKATI TAILA WILL BE ADMINISTERED TO THE PATIENTS FOR 30 MINUTES FOR 7 CONSECUTIVE DAYS Control Intervention1: KATI BASTI WIT

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with lakshanas of Gridhrasi Subjects presenting with clinical features of Sciatica Subjects fit for Kati Basti

Exclusion criteria

Exclusion criteria: Subjects with fractures of Lumbar Spine Spinal Tumor and Tuberculosis of Vertebra Subjects embedded with any metallic implant Subjects with any systemic disease that may interfere with the course of treatment

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE THERAPEUTIC EFEFCT OF KATI BASTI WITH MOORCHITA TAILA AND ERANDAKARKATI TAILA IN GRIDHRASITimepoint: 7 DAYS	—

Secondary

Measure	Time frame
TO COMPARE THE THERAPEUTIC EFEFCT OF KATI BASTI WITH MOORCHITA TAILA AND ERANDAKARKATI TAILA IN GRIDHRASITimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Vinay Kumar K N

SKAMCH RC

knv.gowda@gmail.com9845617690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026